Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells

Affiliations

• 1 Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, 94720, USA.
• 2 The Henry Wheeler Center for Emerging and Neglected Diseases, 344 Li Ka Shing, Berkeley, CA, 94720, USA.
• 3 Department of Molecular and Cell Biology, Division of Immunology and Pathogenesis, University of California, Berkeley, CA, 94720, USA.
• 4 Department of Nutritional Sciences & Toxicology, University of California, Berkeley, CA, 94720, USA.
• 5 Innovative Genomics Institute, University of California, Berkeley, CA, 94720, USA.
• 6 Department of Molecular and Cell Biology, Division of Genetics, Genomics and Development, University of California, Berkeley, CA, 94720, USA.
• 7 Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.
• 8 Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
• 9 Department of Chemistry, Columbia University, New York, NY, 10027, USA.
• 10 Laboratory of Structural Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.
• 11 Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY, 10065, USA.
• 12 Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, 10032, USA.
• 13 Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, 94720, USA. sastanley@berkeley.edu.
• 14 Department of Molecular and Cell Biology, Division of Immunology and Pathogenesis, University of California, Berkeley, CA, 94720, USA. sastanley@berkeley.edu.
• 15 The Henry Wheeler Center for Emerging and Neglected Diseases, 344 Li Ka Shing, Berkeley, CA, 94720, USA. jschaletzky@berkeley.edu.
• # Contributed equally.